ALSENLITE
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALSENLITE, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: ALSENLITE: Senolytics for Alzheimer's Disease [Phase 1, Phase 2]